Skip to content

Drug interactions

Dacomitinib + Tolterodine

Severity: Moderate

Dacomitinib and Tolterodine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dacomitinib strongly inhibits CYP2D6, the main route of tolterodine conversion to its active metabolite. Parent tolterodine exposure may rise, with more anticholinergic effects, though CYP3A4 offers an alternative pathway.

What this interaction means in plain words

Dacomitinib and Tolterodine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Dacomitinib belongs to Oncology; Tolterodine belongs to Genitourinary.

Evidence level: Moderate

Why it happens

CYP2D6 inhibition by dacomitinib reduces tolterodine metabolism.

What to do

Monitor for anticholinergic effects such as dry mouth, constipation and urinary retention, and lower the tolterodine dose if they occur.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dacomitinib and Tolterodine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dacomitinib with Tolterodine?

MediHelp rates the interaction as moderate. Dacomitinib and Tolterodine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Dacomitinib strongly inhibits CYP2D6, the main route of tolterodine conversion to its active metabolite. Parent tolterodine exposure may rise, with more anticholinergic effects, though CYP3A4 offers an alternative pathway.

How serious is the interaction between Dacomitinib and Tolterodine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for anticholinergic effects such as dry mouth, constipation and urinary retention, and lower the tolterodine dose if they occur.

What other medicines interact with Tolterodine?

MediHelp also lists interactions of Tolterodine with, for example, Clarithromycin, Clozapine, Cobicistat. The full list is on the Tolterodine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in